Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Crea

Showing results (71-80 of 138) with videos related to

Pageof 14
Sort By:
Advanced Drug Delivery Reviews|March 19, 2009
Pharmacogenomics in non-small-cell lung cancer chemotherapyRomano Danesi, Giuseppe Pasqualetti, Elisa Giovannetti, et al.
Epigenomics|October 22, 2021
<i>HAR1</i>: an insight into lncRNA genetic evolutionElla Waters, Perla Pucci, Mark Hirst, et al.
Cancer Metastasis Reviews|June 20, 2012
EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesisFrancesco Crea, Lorenzo Fornaro, Guido Bocci, et al.
Future Oncology (London, England)|January 23, 2020
The Open University's first one-day symposium on treatment-emergent neuroendocrine prostate cancerRebecca L Mather, Henry Andrews, Hardev Pandha, et al.
Biomarkers in Medicine|March 28, 2012
An aromatase polymorphism (g.132810C>T) predicts risk of bisphosphonate-related osteonecrosis of the jawFabio La Ferla, Elisa Paolicchi, Francesco Crea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2012
Prognostic value of CD133 caused by mutant K-Ras and B-Raf--letterLorenzo Fornaro, Francesco Crea, Gianluca Masi, et al.
Biophysical Chemistry|February 10, 2017
Potentiometric, UV and <sup>1</sup>H NMR study on the interaction of penicillin derivatives with Zn(II) in aqueous solutionPaola Cardiano, Rosalia Maria Cigala, Francesco Crea, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|September 30, 2011
Epigenetics and chemoresistance in colorectal cancer: an opportunity for treatment tailoring and novel therapeutic strategiesFrancesco Crea, Stefania Nobili, Elisa Paolicchi, et al.
Epigenomics|September 17, 2020
EZH2 inhibition: a promising strategy to prevent cancer immune editingNing Kang, Mark Eccleston, Pier-Luc Clermont, et al.
Fetal Diagnosis and Therapy|February 8, 2017
The IONA® Test: Development of an Automated Cell-Free DNA-Based Screening Test for Fetal Trisomies 13, 18, and 21 That Employs the Ion Proton Semiconductor Sequencing PlatformFrancesco Crea, Matthew Forman, Rachel Hulme, et al.
Pageof 14

Showing results (71-80 of 138) with videos related to

Sort By:
Pageof 14
Advanced Drug Delivery Reviews|March 19, 2009
Pharmacogenomics in non-small-cell lung cancer chemotherapyRomano Danesi, Giuseppe Pasqualetti, Elisa Giovannetti, et al.
Epigenomics|October 22, 2021
<i>HAR1</i>: an insight into lncRNA genetic evolutionElla Waters, Perla Pucci, Mark Hirst, et al.
Cancer Metastasis Reviews|June 20, 2012
EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesisFrancesco Crea, Lorenzo Fornaro, Guido Bocci, et al.
Future Oncology (London, England)|January 23, 2020
The Open University's first one-day symposium on treatment-emergent neuroendocrine prostate cancerRebecca L Mather, Henry Andrews, Hardev Pandha, et al.
Biomarkers in Medicine|March 28, 2012
An aromatase polymorphism (g.132810C>T) predicts risk of bisphosphonate-related osteonecrosis of the jawFabio La Ferla, Elisa Paolicchi, Francesco Crea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2012
Prognostic value of CD133 caused by mutant K-Ras and B-Raf--letterLorenzo Fornaro, Francesco Crea, Gianluca Masi, et al.
Biophysical Chemistry|February 10, 2017
Potentiometric, UV and <sup>1</sup>H NMR study on the interaction of penicillin derivatives with Zn(II) in aqueous solutionPaola Cardiano, Rosalia Maria Cigala, Francesco Crea, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|September 30, 2011
Epigenetics and chemoresistance in colorectal cancer: an opportunity for treatment tailoring and novel therapeutic strategiesFrancesco Crea, Stefania Nobili, Elisa Paolicchi, et al.
Epigenomics|September 17, 2020
EZH2 inhibition: a promising strategy to prevent cancer immune editingNing Kang, Mark Eccleston, Pier-Luc Clermont, et al.
Fetal Diagnosis and Therapy|February 8, 2017
The IONA® Test: Development of an Automated Cell-Free DNA-Based Screening Test for Fetal Trisomies 13, 18, and 21 That Employs the Ion Proton Semiconductor Sequencing PlatformFrancesco Crea, Matthew Forman, Rachel Hulme, et al.
Pageof 14